Literature DB >> 23323033

Treatment of hemodialysis vascular access rupture irresponsive to prolonged balloon tamponade: retrospective evaluation of the effectiveness of N-butyl cyanoacrylate seal-off technique.

Mei-Jui Weng1, Matt Chiung-Yu Chen, Huei-Lung Liang, Huay-Ben Pan.   

Abstract

OBJECTIVE: The current study retrospectively evaluated whether the percutaneous N-butyl cyanoacrylate (NBCA) seal-off technique is an effective treatment for controlling the angioplasty-related ruptures, which are irresponsive to prolonged balloon tamponade, during interventions for failed or failing hemodialysis vascular accesses.
MATERIALS AND METHODS: We reviewed 1588 interventions performed during a 2-year period for dysfunction and/or failed hemodialysis vascular access sites in 1569 patients. For the angioplasty-related ruptures, which could not be controlled with repeated prolonged balloon tamponade, the rupture sites were sealed off with an injection of a glue mixture (NBCA and lipiodol), via a needle/needle sheath to the rupture site, under a sonographic guidance. Technical success rate, complications and clinical success rate were reported. The post-seal-off primary and secondary functional patency rates were calculated by a survival analysis with the Kaplan-Meier method.
RESULTS: Twenty ruptures irresponsive to prolonged balloon tamponade occurred in 1588 interventions (1.3%). Two technical failures were noted; one was salvaged with a bailout stent-graft insertion and the other was lost after access embolization. Eighteen accesses (90.0%) were salvaged with the seal-off technique; of them, 16 ruptures were completely sealed off, and two lesions were controlled as acute pseudoaneurysms. Acute pseudoaneurysms were corrected with stentgraft insertion in one patient, and access ligation in the other. The most significant complication during the follow-up was delayed pseudoaneurysm, which occurred in 43.8% (7 of 16) of the completely sealed off accesses. Delayed pseudoaneurysms were treated with surgical revision (n = 2), access ligation (n = 2) and observation (n = 3). During the follow-up, despite the presence of pseudoaneurysms (acute = 1, delayed = 7), a high clinical success rate of 94.4% (17 of 18) was achieved, and they were utilized for hemodialysis at the mean of 411.0 days. The post-seal-off primary patency vs. secondary patency at 90, 180 and 360 days were 66.7 ± 11.1% vs. 94.4 ± 5.4%; 33.3 ± 11.1% vs. 83.3 ± 8.8%; and 13.3 ± 8.5% vs. 63.3 ± 12.1%, respectively.
CONCLUSION: Our results suggest that the NBCA seal-off technique is effective for immediate control of a venous rupture irresponsive to prolonged balloon tamponade, during interventions for hemodialysis accesses. Both high technical and clinical success rates can be achieved. However, the treatment is not durable, and about 40% of the completely sealed off accesses are associated with developed delayed pseudoaneurysms in a 2-month of follow-up. Further repair of the vascular tear site, with surgery or stent-graft insertion, is often necessary.

Entities:  

Keywords:  Aneurysm, false; Angioplasty, balloon; Arteriovenous shunt, surgical; Cyanoacrylates; Rupture

Mesh:

Substances:

Year:  2012        PMID: 23323033      PMCID: PMC3542305          DOI: 10.3348/kjr.2013.14.1.70

Source DB:  PubMed          Journal:  Korean J Radiol        ISSN: 1229-6929            Impact factor:   3.500


  19 in total

1.  Treatment of stenosis and thrombosis in haemodialysis fistulas and grafts by interventional radiology.

Authors:  L Turmel-Rodrigues; J Pengloan; S Baudin; D Testou; M Abaza; G Dahdah; A Mouton; D Blanchard
Journal:  Nephrol Dial Transplant       Date:  2000-12       Impact factor: 5.992

Review 2.  Reporting standards for percutaneous interventions in dialysis access.

Authors:  Richard J Gray; David Sacks; Louis G Martin; Scott O Trerotola
Journal:  J Vasc Interv Radiol       Date:  2003-09       Impact factor: 3.464

3.  Management of complications of endovascular dialysis access procedures.

Authors:  Gerald A Beathard
Journal:  Semin Dial       Date:  2003 Jul-Aug       Impact factor: 3.455

Review 4.  Role of stents and stent grafts in management of hemodialysis access complications.

Authors:  Thomas M Vesely
Journal:  Semin Vasc Surg       Date:  2007-09       Impact factor: 1.000

5.  Procedural success and patency after percutaneous treatment of thrombosed autogenous arteriovenous dialysis fistulas.

Authors:  Dheeraj K Rajan; Timothy W I Clark; Martin E Simons; John R Kachura; Kenneth Sniderman
Journal:  J Vasc Interv Radiol       Date:  2002-12       Impact factor: 3.464

6.  Endovascular management of immediate procedure-related complications of failed hemodialysis access recanalization.

Authors:  Dong Hun Kim; Dong Erk Goo; Seung Boo Yang; Cheul Moon; Deuk Lin Choi
Journal:  Korean J Radiol       Date:  2005 Jul-Sep       Impact factor: 3.500

7.  Endovascular revascularization of chronically thrombosed arteriovenous fistulas and grafts for hemodialysis: a retrospective study in 15 patients with 18 access sites.

Authors:  Mei-Jui Weng; Matt Chiung-Yu Chen; Wen-Che Chi; Yi-Chun Liu; Huei-Lung Liang; Huay-Ben Pan
Journal:  Cardiovasc Intervent Radiol       Date:  2010-06-29       Impact factor: 2.740

Review 8.  Recommended standards for reports dealing with arteriovenous hemodialysis accesses.

Authors:  Anton N Sidawy; Richard Gray; Anatole Besarab; Mitchell Henry; Enrico Ascher; Michael Silva; Arnold Miller; Larry Scher; Scott Trerotola; Roger T Gregory; Robert B Rutherford; K Craig Kent
Journal:  J Vasc Surg       Date:  2002-03       Impact factor: 4.268

9.  Incidence and management of percutaneous transluminal angioplasty-induced venous rupture in the "fistula first" era.

Authors:  Zev Noah Kornfield; Andrew Kwak; Michael C Soulen; Aalpen A Patel; Sidney M Kobrin; Raphael M Cohen; Mark D Mantell; Jesse L Chittams; Scott O Trerotola
Journal:  J Vasc Interv Radiol       Date:  2009-04-22       Impact factor: 3.464

10.  Efficacy of acrylate tissue adhesive as vascular repair and hemostatic material.

Authors:  Bassem Y Sheikh
Journal:  Ann Vasc Surg       Date:  2007-01       Impact factor: 1.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.